VSIR and leukemia: Similar results were also observed using a different anti–mPD-1H mAb (clone mam82) (48) and using another leukemia model (WEHI3) (Supplemental Figure 13, E and F) in PD-1H–KO mice, where PD-1H blockade was associated with increased T cell infiltration (Supplemental Figure 13G).